Cas:75-37-6 Difluoroethane manufacturer & supplier

Chemical Name:Difluoroethane

CAS.NO:75-37-6

Synonyms:MFCD00000449;Difluoroethane;EINECS 200-866-1

Molecular Formula:C₂H₄F₂

Molecular Weight:66.05000

HS Code:2903399090

Physical and Chemical Properties:

Melting point:-117 °C

Boiling point:-25 °C

Density:0.966

Index of Refraction:1.3011 (-72ºC)

PSA:

Exact Mass:66.02810

LogP:1.27140

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:UN 1030 2.1

Packing Group:

Contact us for information like MFCD00000449 chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,EINECS 200-866-1 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,EINECS 200-866-1 Use and application,MFCD00000449 technical grade,usp/ep/jp grade.

Related News: The rigosertib Pre-approval Access Program is expected to launch in first half of 2020 and will allow Inceptua to supply intravenous rigosertib within designated countries, primarily and initially concentrated in selected countries in Europe, in response to physician requests for patients with higher-risk MDS who have exhausted all available treatment options, and are not eligible for or have no access to the INSPIRE study. Difluoroethane manufacturer The rigosertib Pre-approval Access Program is expected to launch in first half of 2020 and will allow Inceptua to supply intravenous rigosertib within designated countries, primarily and initially concentrated in selected countries in Europe, in response to physician requests for patients with higher-risk MDS who have exhausted all available treatment options, and are not eligible for or have no access to the INSPIRE study. Difluoroethane supplier Aduhelm, however, is in a different league in terms of the number of potential patients and cost to the healthcare system. Difluoroethane vendor A November 2020 analysis by researchers at the University of Oxford found Innova’s tests could be more or less accurate depending on who was using them—ranging from lab scientists to trained healthcare professionals to the general public—but determined the tests overall had a low failure rate and high specificity, despite some variations seen in production batches. Still, Innova’s test and antigen diagnostics more broadly have been seen as less accurate compared to gold-standard, lab-based PCR screening. Difluoroethane factory The rigosertib Pre-approval Access Program is expected to launch in first half of 2020 and will allow Inceptua to supply intravenous rigosertib within designated countries, primarily and initially concentrated in selected countries in Europe, in response to physician requests for patients with higher-risk MDS who have exhausted all available treatment options, and are not eligible for or have no access to the INSPIRE study.